Serum Institute of India to provide corona vaccine, a dose of Rs 225

After the approval of trial of Oxford and AstraZeneca's Corona vaccine, Pune-based Serum Institute of India has stepped up the preparation and distribution of the vaccine in the country.

The Serum Institute of India (SII) said on Friday (7 August) that it has collaborated with the Gavi and Bill & Melinda Gates Foundation to produce 100 million doses of the covid-19 vaccine for India and other low and middle-income countries. Have alliances "This alliance will provide the upfront capital to the Serum Institute to help increase manufacturing capacity, so that once a vaccine or vaccine is approved by regulatory approvals and the World Health Organization, Gavi Covacs Under AMC, by the first half of 2021 enough doses can be produced for distribution in India and other low-middle-income countries. "
Serum Institute of India to provide corona vaccine, a dose of Rs 225
Serum Institute of India to provide corona vaccine, a dose of Rs 225

The company said that it has set an affordable rate of three dollars per dose, or about 225 rupees. This financing will also provide support in the manufacture of potential vaccines for AstraZeneca and Novavax. Vaccines of these two companies are currently undergoing testing. The Bill & Melinda Gates Foundation will provide $ 150 million of risk-free funding to Gavi through its investment fund, to be used to support the Serum Institute in manufacturing potential vaccines and to purchase vaccines for low and middle-income countries in the future Will be done in

Serum Institute of India Chief Executive Officer (CEO) Adar Poonawala said, "In an effort to strengthen our fight against covid-19, the Serum Institute has introduced covid-19 vaccines for India and low and middle income countries. Has collaborated with Gavi and the Bill & Melinda Gates Foundation to produce 100 million doses. "

Renu Swaroop, Secretary, Department of Biotechnology, Government of India, said, "We are very happy to see this global partnership to respond to the global health crisis presented by covid-19 of Serum Institute." He said that India not only has India has a proven track record of producing safe and affordable effective vaccines, but also for the world.

Vaccine will be registered in Russia on August 12, vaccination will start in October

Russia has made a big claim about the corona vaccine that everyone in the world is waiting for. Russia's Health Minister Mikhail Murashko has said the vaccine has been successful in trials and vaccination will begin in the country from October. Meanwhile, Russia's Deputy Health Minister Oleg Gridnev said that Russia will register the world's first corona virus vaccine on 12 August.

This vaccine has been prepared jointly by Gamalaya Research Institute and Russian Defense Ministry. "The development vaccine at Gamalaya Center will be registered on August 12," said Gridnev. Currently the third and final phase is undergoing trials. Trials are extremely important. We have to understand that the vaccine should be completely safe. Medical personnel and senior citizens will be the first to be vaccinated. ''
Serum Institute of India to provide corona vaccine, a dose of Rs 225
Serum Institute of India to provide corona vaccine, a dose of Rs 225

Trial for this vaccine began on 18 June, in which 38 people were vaccinated. Immunity was developed among all the people. The first group was discharged on 15 July and the second group on 20 July. Russia claims that it is going to be the first country to approve the covid-19 vaccine where mass vaccination will be done in early October with the help of vaccines that have not yet completed clinical trials. Scientists around the world are worried that this race to come first will not prove to be the opposite.

Moscow is looking to achieve a publicized victory like Sputnik (Earth's first artificial satellite) that reminds of the Soviet Union's launch of the world's first satellite in 1957. But the first human trials of experimental covid-19 vaccines on some people began about two months ago and no scientific evidence has so far been published to support Russia's claim in the global vaccine-making process. It is not yet clear why he would be considered at the forefront of this endeavor.

Lawrence Gostin, a global public health law specialist at Georgetown University, said, "I am worried that Russia is too hasty so that the vaccine will not only be ineffective but also unsafe." Does ... First of all there should be tests. He is the most important. ''

According to Kirill Dimitryev, head of Russia's Direct Investment Fund, who sponsored the effort, the vaccine developed by the Gamalaya Research Institute will be approved in a few days and before scientists complete the Phase III study. Last-stage studies are the only way to prove that an experimental vaccine is safe and effective. Testing is done on millions of people in this phase.
Serum Institute of India to provide corona vaccine, a dose of Rs 225
Serum Institute of India to provide corona vaccine, a dose of Rs 225

Health Minister Mikhail Murashko said members of 'risk groups', such as medical professionals, could be vaccinated this month. He did not clarify whether he would be part of the Phase III study that would have to be completed after the vaccine received "conditional approval".

Deputy Prime Minister Tatyana Golikova promised to start 'industrial production' in September and Murashko has said that mass-level vaccination will begin in October. This quick approach was questioned last week by America's top infectious disease specialist, Dr. Anthony Fauchi.

BCG vaccine does not increase the risk of coronavirus

Scientists have drawn comparisons between volunteers who were vaccinated against BCG and those who had not been vaccinated. Scientists found that people vaccinated with BCG during the covid-19 pandemic did not fall ill or become more seriously ill. The BCG vaccine was given in the last five years. Their immune system was compared to healthy volunteers who were not vaccinated.

The BCG vaccine was originally intended to treat tuberculosis (TB), according to scientists involved in the study, including Radboud University in Nirdland, but later proved effective in long-term strengthening of the immune system. However he also warned that there are limitations to this study that prevent the conclusion of the benefits of the BCG vaccine against covid-19.

ICMR will study the effect of BCG vaccine

Earlier, the Indian Council of Medical Research (ICMR) announced that it would study whether the BCG vaccine used against TB could prevent coronavirus infection. Also, can it reduce disease severity and mortality in elderly people living in areas of epidemic hotspots. An ICMR scientist said the study would be carried out in Tamil Nadu, Maharashtra, Gujarat, Madhya Pradesh, Rajasthan and Delhi on some 1,500 healthy volunteers over the age of 60.
Serum Institute of India to provide corona vaccine, a dose of Rs 225
Serum Institute of India to provide corona vaccine, a dose of Rs 225

ICMR's National Tuberculosis Research Institute (NIRT) of Chennai has been approved by the Tamil Nadu government for testing on July 15. Under this, the effectiveness of BCG vaccine on the elderly will be studied. The BCG-COVID trial will also take place at five other centers under ICMR. These include the All India Institute of Ayurvedic Sciences, Delhi, besides the institutes of Ahmedabad, Bhopal, Mumbai, Jodhpur.



Comments

Popular posts from this blog

The world's first corona vaccine will be registered

ICMR to examine antibodies to corona vaccine given in Patna AIIMS

World Health Organization has warned that the world should be prepared for the next Pandemic